TORONTO -- (MARKET WIRE) -- September 19, 2006 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that internationally renowned diabetes investigators Professor Paolo Pozzilli and Dr. Marta Vadacca, both of the Department of Endocrinology and Diabetes at University Campus Bio-Medico, Rome, Italy, made a podium presentation of the results of a research project sponsored by Antigen Express, Inc., a wholly owned subsidiary of the Company, at the 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD) (www.easd.org) in Copenhagen, Denmark, on September 17, 2006.
